MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias

CXCR4 is a negative prognostic marker in acute myeloid leukemias (AMLs). Therefore, it is necessary to develop novel ways to inhibit CXCR4 expression in leukemia. AMD3100 is an inhibitor of CXCR4 currently used to mobilize cancer cells. CXCR4 is a target of microRNA (miR)-146a that may represent a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinello, I, Quaranta, M T, Riccioni, R, Riti, V, Pasquini, L, Boe, A, Pelosi, E, Vitale, A, Foà, R, Testa, U, Labbaye, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255264/
https://www.ncbi.nlm.nih.gov/pubmed/22829170
http://dx.doi.org/10.1038/bcj.2011.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255264/
https://www.ncbi.nlm.nih.gov/pubmed/22829170
http://dx.doi.org/10.1038/bcj.2011.24

Ejemplares similares